SGMO - Sangamo Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.15B
Enterprise Value 3812.16M
Trailing P/E N/A
Forward P/E 1-7.66
PEG Ratio (5 yr expected) 10.34
Price/Sales (ttm)14.38
Price/Book (mrq)3.10
Enterprise Value/Revenue 310.17
Enterprise Value/EBITDA 6-8.51

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -113.03%
Operating Margin (ttm)-122.61%

Management Effectiveness

Return on Assets (ttm)-14.86%
Return on Equity (ttm)-35.54%

Income Statement

Revenue (ttm)79.89M
Revenue Per Share (ttm)0.79
Quarterly Revenue Growth (yoy)-36.10%
Gross Profit (ttm)-30.41M
EBITDA -95.46M
Net Income Avi to Common (ttm)-90.3M
Diluted EPS (ttm)-0.89
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)351M
Total Cash Per Share (mrq)3.04
Total Debt (mrq)14.62M
Total Debt/Equity (mrq)4.44
Current Ratio (mrq)3.98
Book Value Per Share (mrq)3.21

Cash Flow Statement

Operating Cash Flow (ttm)10.17M
Levered Free Cash Flow (ttm)-53.47M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.28
52-Week Change 3-36.22%
S&P500 52-Week Change 38.59%
52 Week High 319.25
52 Week Low 36.26
50-Day Moving Average 39.80
200-Day Moving Average 310.53

Share Statistics

Avg Vol (3 month) 31.97M
Avg Vol (10 day) 31.29M
Shares Outstanding 5115.36M
Float 115.25M
% Held by Insiders 10.39%
% Held by Institutions 157.39%
Shares Short (May 31, 2019) 414.86M
Short Ratio (May 31, 2019) 49.95
Short % of Float (May 31, 2019) 412.92%
Short % of Shares Outstanding (May 31, 2019) 412.88%
Shares Short (prior month Apr 30, 2019) 413.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A